Cas:3095-73-6 hexakis(bromomethyl)benzene manufacturer & supplier

We serve Chemical Name:hexakis(bromomethyl)benzene CAS:3095-73-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

hexakis(bromomethyl)benzene

Chemical Name:hexakis(bromomethyl)benzene
CAS.NO:3095-73-6
Synonyms:MFCD00182539;1,2,3,4,5,6-HEXAKIS-BROMOMETHYL-BENZENE;Benzene,hexakis(bromomethyl);Hexa(bromomethyl)benzene;1,2,3,4,5,6-hexakis(bromomethyl)-benzene;Hexakis(bromomethyl)benzene;EINECS 221-443-8
Molecular Formula:C12H12Br6
Molecular Weight:635.64800
HS Code:2903999090

Physical and Chemical Properties:
Melting point:295-297 °C(lit.)
Boiling point:498.3ºC at 760mmHg
Density:2.386g/cm3
Index of Refraction:1.692
PSA:
Exact Mass:629.60400
LogP:7.05600

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3261 8/PG 2
Packing Group:III


Contact us for information like MFCD00182539 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 221-443-8 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,2,3,4,5,6-HEXAKIS-BROMOMETHYL-BENZENE Use and application,1,2,3,4,5,6-hexakis(bromomethyl)-benzene technical grade,usp/ep/jp grade.


Related News: With no new systemic lupus erythematosus treatments in over a decade, we’re working to make this new medicine available as soon as possible.” S-ethyl N-(furan-2-ylmethyl)carbamothioate manufacturers One way of leveraging the many benefits of biocatalysis is to partner with an API CDMO offering comprehensive expertise and experience in developing and implementing such technology in GMP commercial production. (1R,2R,6S,7R)-3,5-Dioxa-tricyclo[5.2.1.02,6]decane suppliers Earlier this year, the US Food and Drug Administration approved Verquvo to reduce the risk of cardiovascular death and heart failure hospitalisation, following a hospitalisation for heart failure or need for outpatients intravenous (IV) diuretics in adults with symptomatic chronic heart failure and ejection fraction less than 45%. methyl 3-oxo-6-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-2,3-dihydropyridazine-4-carboxylate vendor & factory.